XOMA Corp (NAS:XOMAO.PFD)
$ 25.1 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 3.61 GF Score: 49/100

XOMA Corp at Cowen Health Care Conference Transcript

Mar 12, 2019 / 04:00PM GMT
Joe Thome
Cowen and Company - Analyst

Welcome to the 39th annual Cowen and Company healthcare conference. I am Joe Thome, one of the members of the biotech team here at Cowen.

It is my pleasure to introduce XOMA today and CEO Jim Neal, who is going to give us an update on the Company.

Jim Neal
XOMA Corporation - CEO

Thank you, Joe. Welcome. With me today I have Tom Burns, our CFO, here to answer questions should we get to that point. And also with Tom is Juliane Snowden, who handles our investor relations.

So welcome to the XOMA story. It is a biotech story that doesn't look like a biotech story. I hope you appreciate I think a very interesting model that we actually introduced exactly two years ago at this conference and have been working diligently to make effective since that point in time.

We will be making forward-looking statements. I would refer you to our SEC filings to apprise yourself of the risks associated with investing in biotech, which we all are very aware of.

Let's just talk about XOMA and what we are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot